|
ZNF415 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.76200000040683E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.961700E-04 |
| Normal-vs-Stage2 |
1.281020E-01 |
| Normal-vs-Stage3 |
3.62910035356379E-10 |
| Normal-vs-Stage4 |
5.48809997447108E-10 |
| Stage1-vs-Stage2 |
3.318600E-01 |
| Stage1-vs-Stage3 |
5.80940000000085E-05 |
| Stage1-vs-Stage4 |
3.81289999995538E-06 |
| Stage2-vs-Stage3 |
2.140800E-03 |
| Stage2-vs-Stage4 |
6.036800E-04 |
| Stage3-vs-Stage4 |
4.687200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.44680000038855E-07 |
| Normal-vs-AfricanAmerican |
3.320600E-03 |
| Normal-vs-Asian |
1.771620E-01 |
| Caucasian-vs-AfricanAmerican |
3.794800E-01 |
| Caucasian-vs-Asian |
7.285400E-01 |
| AfricanAmerican-vs-Asian |
9.987600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.96620000001169E-06 |
| Normal-vs-Female |
1.76260000039896E-07 |
| Male-vs-Female |
5.190600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.606640E-04 |
| Normal-vs-Age(41-60Yrs) |
1.974520E-04 |
| Normal-vs-Age(61-80Yrs) |
5.8260000046495E-08 |
| Normal-vs-Age(81-100Yrs) |
6.802500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.339900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.465000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.822800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.806770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.030800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.680800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.629400E-01 |
| Normal-vs-Grade 2 |
2.036900E-03 |
| Normal-vs-Grade 3 |
5.22490000154363E-08 |
| Normal-vs-Grade 4 |
3.38939987187814E-12 |
| Grade 1-vs-Grade 2 |
6.808200E-01 |
| Grade 1-vs-Grade 3 |
1.336160E-01 |
| Grade 1-vs-Grade 4 |
8.391000E-04 |
| Grade 2-vs-Grade 3 |
6.382500E-03 |
| Grade 2-vs-Grade 4 |
7.08089997747408E-09 |
| Grade 3-vs-Grade 4 |
7.010400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.398200E-04 |
| Normal-vs-ccB subtype |
2.38109999999292E-05 |
| ccA subtype-vs-ccB subtype |
2.794400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.85780000000668E-05 |
| Normal-vs-N1 |
1.279580E-03 |
| N0-vs-N1 |
2.541000E-01 |
|
|
